Keertan Dheda

From Wikipedia, the free encyclopedia

Keertan Dheda
Professor Keertan Dheda.png
Born1969 (age 53–54)
NationalityBritish; South African
Occupation(s)Researcher; professor; medical doctor
Known forScientific contributions to the field of respiratory infections including tuberculosis.
Academic background
Alma materUniversity of Witwatersrand, University College London
Academic work
Sub-disciplineRespiratory Medicine; Immunology; Antimicrobial Resistance; Tuberculosis
InstitutionsLondon School of Hygiene and Tropical Medicine, University of Cape Town, University College London,

Keertan Dheda MBBCh (Wits), FCP(SA), FCCP, PhD (Lond), FRCP (Lond), born in 1969, is a Professor of Mycobacteriology and Global health at the London School of Hygiene and Tropical Medicine (LSHTM) with an extra-mural joint appointment at the University of Cape Town (UCT), where he is a Professor of Respiratory Medicine.[1][2]

He is a global research leader in TB diagnosis and transmission, having published over 320 peer-reviewed papers, with a Google h-index of 87[3] and Scopus h-Index of 70 (As of 2022).[4]


His research work focuses on the molecular epidemiology, diagnosis, transmission, and treatment of Tuberculosis, as well as antimicrobial resistance of pulmonary pathogens such as Mycobacterium tuberculosis.[5] He has a keen interest in medical education and interventional pulmonology including bronchial thermoplasty, ultrasound-guided mediastinal biopsy (EBUS TBNA) and medical thoracoscopy.

Awards and recognition[edit]

He received the International Union Against Tuberculosis and Lung Disease Scientific Award,[6] and the 2018 European Union-funded EDCTP Scientific Leadership Award.[7] Other awards have included the Harry Oppenheimer Fellowship Award, the NSTF BHP-Billiton Research award,[8] and MRC Scientific Achievement Award (Platinum). He has been profiled in The Lancet,[9] the Business Day newspaper,[10] IOL,[11] News24,[12] and Carte Blanche, a high-profile news programme in South Africa.


He serves or has served on the editorial board of the journals American Journal of Respiratory and Critical Care Medicine, Lancet Respiratory Medicine, PLOS One, and Scientific Reports, amongst others. He is a former president of the South African Thoracic Society,[13] is the founder and co-director of the charity, Free of TB,[14] which provides support and healthcare to poor and needy persons afflicted with TB.

See also[edit]


  1. ^ "Keertan Dheda". LSHTM. Retrieved 3 November 2021.
  2. ^ "Prof Keertan Dheda". UCT Lung Institute. Retrieved 3 November 2021.
  3. ^ Keertan Dheda publications indexed by Google Scholar
  4. ^ Keertan Dheda publications indexed by the Scopus bibliographic database. (subscription required)
  5. ^ Dheda, Keertan. "Research work". University of Cape Town Lung Institute. Retrieved 29 May 2018.
  6. ^ "The Union Scientific Prize". The Union. Retrieved 6 July 2018.
  7. ^ "UCT's leading TB researcher receives top international science prize".
  8. ^ "NSTF Winners Press Release" (PDF).
  9. ^ Dheda, Keertan (2014). "Rising star of pulmonology". The Lancet. 383 (9915): 403. doi:10.1016/S0140-6736(14)60140-9. PMID 24485575. S2CID 40910739. Retrieved 29 May 2018.
  10. ^ Dheda, Keertan. "Man on a mission". Press Reader. Retrieved 29 May 2018 – via PressReader.
  11. ^ "UCT to spearhead research into antibiotic resistance | Cape Times". Retrieved 5 July 2018.
  12. ^ "TB bomb set to expolde". News24. Retrieved 5 July 2018.
  13. ^ Dheda, Keertan. "President of South African Thoracic Society". South African Thoracic Society. Retrieved 29 May 2018.
  14. ^ Dheda, Keertan. "Director and founder of Free of TB charity". Free of TB. Retrieved 29 May 2018.